April 30, 2020 / 12:50 PM / a month ago

BRIEF-Synairgen Says Approval Received To Extend Sg016 Clinical Study Of Sng001 In Covid-19

April 30 (Reuters) - Synairgen PLC:

* SYNAIRGEN PLC - APPROVAL RECEIVED TO EXTEND SG016 CLINICAL STUDY OF SNG001 IN COVID-19 TO INITIATE PATIENTS IN HOME ENVIRONMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below